SMTI ACCUMULATIONwyckof original schematic
after shakeout, present of SOS with LPS
+supply reducing
-expecting JAC after this
so far no warning signs
bias : accumulation
−0.52USD
−4.30 MUSD
64.99 MUSD
3.50 M
About Sanara MedTech Inc.
Sector
Industry
CEO
Zachary B. Fleming
Website
Headquarters
Fort Worth
Employees (FY)
107
Founded
1982
ISIN
US79957L1008
FIGI
BBG000KLGDZ6
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SMTI is 31.60 USD — it has decreased by 0.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sanara MedTech Inc. stocks are traded under the ticker SMTI.
Sanara MedTech Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Sanara MedTech Inc. has a max estimate of 44.00 USD and a min estimate of 44.00 USD.
Sanara MedTech Inc. revenue for the last quarter amounts to 16.02 M USD despite the estimated figure of 18.80 M USD. In the next quarter revenue is expected to reach 16.50 M USD.
Yes, you can track Sanara MedTech Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, SMTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sanara MedTech Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 107.00 employees. See our rating of the largest employees — is Sanara MedTech Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sanara MedTech Inc. EBITDA is −3.85 M USD, and current EBITDA margin is −6.14%. See more stats in Sanara MedTech Inc. financial statements.